[1] NIE H, FANG R, XIONG B Q, et al. Immunogenicity and protective efficacy of two recombinant pseudorabies viruses expressing Toxoplasma gondii SAG1 and MIC3 proteins[J]. Vet Parasitol, 2011, 181(2-4):215-221.
[2] QIU J F, WANG L J, ZHANG R, et al. Identification of a TNF-α inducer MIC3 originating from the microneme of non-cystogenic, virulent Toxoplasma gondii[J]. Sci Rep, 2016, 6:39407.
[3] ZHANG X X, ZHAO Q, SHI C W, et al. Seroprevalence and associated risk factors of Toxoplasma gondii infection in the Korean, Manchu, Mongol and Han ethnic groups in eastern and northeastern China[J]. Epidemiol Infect, 2016, 144(9):2018-2024.
[4] XUE J X, JIANG W, CHEN Y J, et al. Thioredoxin reductase from Toxoplasma gondii:an essential virulence effector with antioxidant function[J]. FASEB J, 2017, 31(10):4447-4457.
[5] ZHENG J, CHEN Y P, LI Z R, et al. Translationally controlled tumor protein is required for the fast growth of Toxoplasma gondii and maintenance of its intracellular development[J]. FASEB J, 2018, 32(2):906-919.
[6] ZHANG X X, REN W X, HOU G Y, et al. Seroprevalence and risk factors of Toxoplasma gondii infection in horses in Jilin province and Inner Mongolia autonomous region, northern China[J]. Acta Trop, 2018, 187:119-123.
[7] YAROVINSKY F. Innate immunity to Toxoplasma gondii infection[J]. Nat Rev Immunol, 2014, 14(2):109-121.
[8] LIU L, LIU L N, WANG P, et al. Elevated seroprevalence of Toxoplasma gondii in AIDS/HIV patients:a meta-analysis[J]. Acta Trop, 2017, 176:162-167.
[9] AKBAR H, DIMIER-POISSON I, MOIRÉN, et al. Role of CD4+ Foxp3+ regulatory T cells in protection induced by a live attenuated, replicating type I vaccine strain of Toxoplasma gondii[J]. Infect Immun, 2015, 83(9):3601-3611.
[10] CHING X T, FONG M Y, LAU Y L. Evaluation of immunoprotection conferred by the subunit vaccines of GRA2 and GRA5 against acute Toxoplasmosis in BALB/c mice[J]. Front Microbiol, 2016, 7:609.
[11] ALIBAKHSHI A, BANDEHPOUR M, KAZEMI B. Cloning, expression and purification of a polytopic antigen comprising of surface antigens of Toxoplasma gondii[J]. Iran J Microbiol, 2017, 9(4):251-256.
[12] TSAI C T, ZULUETA M M L, HUNG S C. Synthetic heparin and heparan sulfate:probes in defining biological functions[J]. Curr Opin Chem Biol, 2017, 40:152-159.
[13] ZHANG Y, JIANG N, JIA B Y, et al. A comparative study on the heparin-binding proteomes of Toxoplasma gondii and Plasmodium falciparum[J]. Proteomics, 2014, 14(15):1737-1745.
[14] ORTEGA-BARRIA E, BOOTHROYD J C. A Toxoplasma Lectin-like activity specific for sulfated polysaccharides is involved in host cell infection[J]. J Biol Chem, 1999, 274(3):1267-1276.
[15] MEISSNER M, SCHLÜ D, SOLDATI D. Role of Toxoplasma gondii myosin a in powering parasite gliding and host cell invasion[J]. Science, 2002, 298(5594):837-840.
[16] WANG Y H, YIN H. Research advances in microneme protein 3 of Toxoplasma gondii[J]. Parasit Vectors, 2015, 8:384.
[17] NI T, WILLIAMS S I, REZELJ S, et al. Structures of monomeric and oligomeric forms of the Toxoplasma gondii perforin-like protein 1[J]. Sci Adv, 2018, 4(3):eaaq0762.
[18] LEE H C. Cyclic ADP-ribose and NAADP:fraternal twin messengers for calcium signaling[J]. Sci China Life Sci, 2011, 54(8):699-711.
[19] LEE H C. Cyclic ADP-ribose and nicotinic acid adenine dinucleotide phosphate (NAADP) as messengers for calcium mobilization[J]. J Biol Chem, 2012, 287(38):31633-31640.
[20] BILLKER O, LOURIDO S, SIBLEY L D. Calcium-dependent signaling and kinases in Apicomplexan parasites[J]. Cell Host Microbe, 2009, 5(6):612-622.
[21] INGRAM J R, KNOCKENHAUER K E, MARKUS B M, et al. Allosteric activation of apicomplexan calcium-dependent protein kinases[J]. Proc Natl Acad Sci U S A, 2015, 112(36):E4975-E4984.
[22] AZZOUZ N, KAMENA F, LAURINO P, et al. Toxoplasma gondii secretory proteins bind to sulfated heparin structures[J]. Glycobiology, 2012, 23(1):106-120.
[23] CARRUTHERS V B, HÅANSSON S, GIDDINGS O K, et al. Toxoplasma gondii uses sulfated proteoglycans for substrate and host cell attachment[J]. Infect Immun, 2000, 68(7):4005-4011.
[24] JACQUET A, COULON L, DE NÈE J, et al. The surface antigen SAG3 mediates the attachment of Toxoplasma gondii to cell-surface proteoglycans[J]. Mol Biochem Parasitol, 2001, 116(1):35-44.
[25] TAKEMAE H, KOBAYASHI K, SUGI T, et al. Toxoplasma gondii RON4 binds to heparan sulfate on the host cell surface[J]. Parasitol Int, 2018, 67(2):123-130. |